Mid-day movers: SMS Pharmaceuticals, Wockhardt and Dodla Dairy are the BSE top gainers!

Mid-day movers: SMS Pharmaceuticals, Wockhardt and Dodla Dairy are the BSE top gainers!

Abhishek Ranawade
/ Categories: Trending, Mindshare

Shares of SMS Pharmaceuticals Ltd, Wockhardt Ltd and Dodla Dairy Ltd have rallied in today’s trading session

While markets opened with a red mark, as of noon, BSE Sensex was 0.33 per cent down, while the smallcap index was 0.74 per cent up.   

SMS Pharmaceuticals Ltd jumps more than 14 per cent 

SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. The company’s stock soared 10 per cent in early trade on Monday after the announcement that the company has a non-exclusive license to manufacture and supply nirmatrelvir (an oral COVID-19 medicine) through the Medicine Patent Pool (MPP). 

Wockhardt Ltd ascends more than 13 per cent 

Wockhardt is a global pharmaceutical and biotech company and is India’s leading research-based global healthcare enterprise. The share has rallied more than 13 per cent in the first half of today's trading session as the company has entered into a collaboration agreement with Serum Life Sciences Ltd, UK, a subsidiary of the Serum Institute of India, one of the world’s largest vaccine manufacturers to deliver a global vaccine programme from its New Facility in the UK. The collaboration will result in a profit-sharing arrangement between the two parties that will deliver upto an additional 150 million vaccine doses of multiple vaccines each year. 

Dodla Dairy Ltd gained more than 8 per cent 

Dodla Dairy Limited is an integrated dairy company based in Telangana. The company derives the majority of its revenue from the sale of milk and dairy-based value-added products in the branded consumer market. On March 19, 2022, the company has executed a Business Transfer Agreement (“Agreement”) with Sri Krishna Milks Private Limited for the acquisition of a business as a “going concern” and on a slump purchase basis for consideration of Rs 50 crore.

Previous Article Five stocks witnessing short covering
Next Article Stocks below Rs 100: Only buyers seen in these scrips on March 21
Rate this article:
3.5

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR